Rye bran diet increases epithelial cell apoptosis and decreases epithelial cell volume in TRAMP (transgenic adenocarcinoma of the mouse prostate) tumors

Nutrition and Cancer

Volumn 53, Issue 1, 2005, Pages 111-116

  Wikström, Pernilla ^a,c   Bylund, Annika ^b   Zhang, Jie Xian ^a   Hallmans, Göran ^a   Stattin, Pär ^a   Bergh, Anders ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAN; CANCER INHIBITION; CANCER MODEL; CELL PROLIFERATION; CONTROLLED STUDY; DIETARY INTAKE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PROSTATE ADENOCARCINOMA; PROSTATE EPITHELIUM; RYE; STEREOMETRY; TRANSGENIC MOUSE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL DIVISION; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; SECALE CEREALE;

ANIMALIA; MUS MUSCULUS; SECALE CEREALE;

EID: 30344432646     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5301_13     Document Type: Article

References (26)

1. Adlercreutz H and Mazur W: Phyto-oestrogens and Western diseases. Ann Med 29, 95-120, 1997.
2. Bingham SA, Atkinson C, Liggins J, Bluck L, and Coward A: Phytoestrogens; where are we now? Br J Nutr 19, 393-406, 1998.
3. Clinton SK and Giovannucci E: Diet, nutrition, and prostate cancer. Annu Rev Nutr 18, 413-440, 1998.
4. Saarinen NM, Warri A, Makela SI, Eckerman C, Reunanen M, et al.: Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer 36, 207-216, 2000.
5. Adlercreutz A: Human health and phytoestrogens. In Reproductive and Developmental Toxicology, Korach KS (ed). New York: Marcel Dekker, 1998, pp 299-371.
6. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, et al.: Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 58, 47-52, 2001.
7. Pukkala E, Gustavsson N, and Teppo L: Atlas of Cancer Incidence in Finland: 1953-82. Helsinki, Finland: Cancer Society of Finland, 1987.
8. Kleemola P, Virtanen M, and Pietinen P: The 1992 Dietary Survey of Finnish Adults. Helsinki, Finland: National Public Health Institute, 1994.
9. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, et al.: Identification of lignans as major components in the phenolic fraction of olive oil. Clin Chem 46, 976-988, 2000.
10. Landstrom M, Zhang JX, Hallmanns G, Åman P, Bergh A, et al.: Inhibitory effects of soy and rye diets on the development of Dunning R3327 prostate adenocarcinoma in rats. Prostate 36, 151-161, 1998.
11. Bylund A, Zhang JX, Bergh A, Damber JE, Widmark A, et al.: Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice. Prostate 42, 304-314, 2000.
12. Bylund A, Lundin E, Zhang JX, Nordin A, Kaaks R, et al.: Randomized controlled short-term intervention pilot study on rye bran bread in prostate cancer. Eur J Cancer Prev 12, 407-415, 2003.
13. Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, et al.: Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 99, 124-129, 2002.
14. Kilkkinen A, Virtamo J, Virtanen MJ, Adlercreutz H, Albanes D, et al.: Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev 12, 1209-1212, 2003.
15. Greenberg NM, DeMayo FJ, Finegold M, Medina D, Tilley WD, et al.: Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92, 3439-3443, 1995.
16. Gingrich JR and Greenberg NM: A transgenic mouse prostate cancer model. Toxicol Pathol 24, 502-504, 1996.
17. Lin X, Gingrich JR, Bao W, Li J, Haaron ZA, et al.: Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. Urology 60, 919-924, 2002.
18. Gingrich JR, Barrios RJ, Foster BA, and Greenberg NM: Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostat Dis 2, 70-75, 1999.
19. Hsu CX, Ross BD, Chrisp CE, Derrow SZ, Charles LG, et al.: Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. J Urol 160, 1500-1505, 1998.
20. Gupta S, Hastak K, Ahmad N, Lewin JS, and Mukhtar H: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 98, 10350-10355, 2001.
21. Martiniello-Wilks R, Dane A, Mortensen E, Jeyakumar G, Wang XY, et al.: Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies. Anticancer Res 23, 2633-2642, 2003.
22. Kaplan-Lefko PJ, Chen T-M, Ittmann MM, Barrios RJ, Ayala GE, et al.: Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55, 219-237, 2003.
23. Wikström P, Lindahl P, and Bergh A: Characterization of the autochthonous Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) as a model to study effects of castration therapy. Prostate 62, 148-164, 2005.
24. Greenberg NM, DeMayo FJ, Sheppard PC, Lebovitz R, Finegold M, et al.: The rat probasin gene promoter directs hormonally- and developmentally-regulated expression of heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8, 230-239, 1994.
25. Franck Lissbrant I, Häggström S, Damber J-E, and Bergh A: Testosterone stimulates angiogenesis and vascular regrowth in the VP prostate in castrated adult rats. Endocrinology 139, 451-456, 1998.
26. Mentor-Marcel R, Lamartiniere CA, Eltoum DE, Greenberg NM, and Elgavish A: Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61, 6777-6782, 2001.